Arrowhead Pharmaceuticals, Inc. (ARWR) vs Cytokinetics, Incorporated (CYTK)

Arrowhead Pharmaceuticals, Inc. and Cytokinetics, Incorporated are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Cytokinetics, Incorporated are of similar size ($9.3B and $9.0B). Arrowhead Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 16.1% against −21.1%. Arrowhead Pharmaceuticals, Inc. has the higher net margin (−47.8% vs −1,321.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 13 and Cytokinetics, Incorporated on 3.

Valuation

Metric ARWR CYTK Biotechnology median
P/E n/m n/m 7.88
P/S 14.12 126.21 11.47
P/B 20.28 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 13.02 125.94 10.73
Earnings yield (3.41%) (11.17%) (28.84%)
Free cash flow yield (0.79%) (6.80%) (23.03%)

Profitability

Metric ARWR CYTK Biotechnology median
Gross margin 100.00% 87.97% 65.16%
Operating margin (33.82%) (1,046.12%) 0.00%
Net margin (47.79%) (1,321.12%) 0.00%
Free cash flow margin (11.22%) (858.16%) 0.00%
Return on equity (64.91%) 329.76% (57.72%)
Return on assets (18.32%) (56.76%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARWR CYTK Biotechnology median
Revenue growth (TTM) 16.13% (21.07%) 5.64%
EPS growth (last fiscal year) 99.80% (24.33%) —
Revenue growth, 5-year CAGR 56.63% 9.54% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARWR CYTK Biotechnology median
Debt to equity 1.85 (6.61) 0.00
Current ratio 5.90 6.66 4.73
Net debt to EBITDA (5.70) (0.46) 0.96

Dividend

Metric ARWR CYTK Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARWR CYTK Biotechnology median
Market cap 9.33b 8.98b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack